Cardiff Oncology, Inc. (CRDF)

[apollo1452]

Shelf Registration Expiration & Replacement

"S-3 Registrations expire after 3 years. The recent shelf registration is merely replacing the original S-3 Registration Statement (effective February 4, 2013). The original S-3 was for $150mm with up to $30mm via Cantor in a Controlled Equity Offering. Over the 3 years, TROV issued 2 offerings from the original S-3 in Feb 2015 and July 2015. As far as I know, no sales to Cantor were made during that time under the Controlled Equity Offering

The new S-3 is for $250mm with up to the same $30mm via Cantor in a Controlled Equity Offering. This does not mean that there is anything imminent on the horizon. At the projected burn rate, TROV will definitely need cash sometime by Q2 2017. But just like in July 2015, I'm sure TROV will be opportunistic if the stock jumps unexpectedly to raise cash. Cash is king in the LB space."

This post is from solo_nyc and IMO summarizes current events very well.